Enspryng

News

Reviews underway of first drug for rare disease MOGAD

Patients with rare autoimmune disease MOGAD could be months away from having a first approved therapy, as the FDA starts a review of Roche's Enspryng.

News

New data build case for Roche's oral BTK drug for MS

Roche remains confident in the prospects for its soon-to-be-filed oral BTK drug fenebrutinib for multiple sclerosis, despite safety concerns.

News

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Roche's Enspryng has been recommended for approval in the EU for treating neuromyelitis optica spectrum disorder (NMOSD), extending the treatment options for people with the life-threatenin

Reviews underway of first drug for rare disease MOGAD

New data build case for Roche's oral BTK drug for MS

CHMP backs Roche's Enspryng for rare nerve disease NMOSD

Click claims FDA okay for first-in-class schizophrenia DTx

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks